Generic
Aptin M 50/850 contains Vildagliptin 50 mg and Metformin Hydrochloride 850 mg, formulated to effectively manage type 2 diabetes mellitus.

Description
Aptin M 50/850 is a combination oral antidiabetic tablet manufactured by ACI Limited. It is designed for patients who require better glycemic control and manufactures this medication as an adjunct to diet and exercise.

Benefits
This combination helps regulate blood sugar levels by enhancing insulin secretion and reducing glucose production. It provides improved glycemic control in patients inadequately managed with either component alone.

Ingredients
The tablet contains Vildagliptin 50 mg and Metformin Hydrochloride 850 mg, which work synergistically to control blood sugar levels in type 2 diabetes patients.

Uses and Doses
Adults should take one tablet twice daily, preferably with food, to minimize gastrointestinal discomfort. Patients switching from separate Vildagliptin and Metformin tablets should continue with the exact dosage.

Side Effects
Common side effects include headache, dizziness, nausea, tremors, and hypoglycemia. In rare cases, lactic acidosis may occur due to Metformin buildup.

How to Use
Swallow the tablet whole with water, preferably with meals. Do not crush or chew. Follow the prescribed dosage strictly to maintain optimal blood sugar levels.

Pregnancy & Lactation
This medication is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Consult a healthcare provider before use.

Precautions and Warnings
Patients with kidney disease, metabolic acidosis, or heart failure should avoid this medication. Routine kidney function tests are necessary for monitoring Metformin-related risks.

Safety Information
Avoid alcohol consumption while taking this medication. If signs of lactic acidosis appear, discontinue use immediately and seek medical help.

Indications
Aptin M 50/850 is prescribed for patients with type 2 diabetes mellitus who require combination therapy for better glycemic control.

Pharmacology
Vildagliptin inhibits DPP-4 enzymes, increasing the incretin hormones GLP-1 and GIP levels. This enhances insulin secretion and reduces glucagon levels. Metformin lowers glucose production in the liver and improves insulin sensitivity.

Therapeutic Class
This medication belongs to the combination oral hypoglycemic drug class used to treat type 2 diabetes.

Storage Conditions
Store below 30°C, away from moisture and direct light. Keep out of children’s reach.

FAQ

1. Can Aptin M 50/850 be taken without food?
   Taking this medication with or after food is recommended to minimize gastrointestinal discomfort.
2. Is this medication safe for elderly patients?
   Yes, but kidney function should be monitored regularly.
3. Can Aptin M 50/850 be used with other antidiabetic drugs?
   There is no clinical experience of its use in triple therapy with other antidiabetic agents.

Disclaimer
This information is for educational purposes only and should not replace medical advice. Consult a healthcare professional before starting or stopping any medication.

Keywords: Aptin M 50/850, Vildagliptin, Metformin Hydrochloride, diabetes medication, type 2 diabetes, ACI Limited, glycemic control, insulin secretion, blood sugar control, diabetic tablets, oral hypoglycemic, DPP-4 inhibitor, Metformin benefits, Vildagliptin effects, diabetes treatment, combination therapy, sugar control medicine, diabetes management, best diabetes pill, glucose regulation, diabetic health.